A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Ps0015 965, Kew Gardens

Ps0015 969, High Point

Ps0015 971, Wilmington

Ps0015 966, Sandy Springs

Ps0015 921, Ormond Beach

Ps0015 977, Pembroke Pines

Ps0015 970, West Palm Beach

Ps0015 936, Tampa

Ps0015 976, Tampa

Ps0015 903, Ocala

Ps0015 980, Bexley

Ps0015 900, West Des Moines

Ps0015 954, Skokie

Ps0015 972, West Dundee

Ps0015 915, Clayton

Ps0015 953, St Louis

Ps0015 944, New Orleans

Ps0015 979, Dallas

Ps0015 924, Houston

Ps0015 978, Pflugerville

Ps0015 975, Santa Ana

Ps0015 920, Portland

Ps0015 929, Portland

Ps0015 939, Danbury

Ps0015 901, Portsmouth

PS0015 3, Carlton

PS0015 7, Hectorville

PS0015 6, Kogarah

Ps0015 11, Parkville

PS0015 9, Woolloongabba

Ps0015 50, Brussels

Ps0015 54, Brussels

Ps0015 52, Liège

Ps0015 673, Halifax

Ps0015 671, Hamilton

Ps0015 663, Mississauga

Ps0015 661, Peterborough

Ps0015 678, Richmond Hill

Ps0015 677, Toronto

Ps0015 657, Waterloo

Ps0015 153, Toulouse

Ps0015 223, Augsburg

Ps0015 237, Berlin

Ps0015 211, Hamburg

Ps0015 215, Lübeck

Ps0015 213, Mahlow

Ps0015 238, Mainz

Ps0015 234, München

Ps0015 219, Münster

Ps0015 236, Neu-Ulm

Ps0015 222, Tübingen

Ps0015 204, Witten

Ps0015 265, Amsterdam

Ps0015 263, Breda

Ps0015 355, Bialystok

Ps0015 361, Bialystok

Ps0015 369, Bialystok

Ps0015 352, Gdansk

Ps0015 366, Katowice

Ps0015 378, Katowice

Ps0015 376, Krakow

Ps0015 379, Krakow

Ps0015 372, Lodz

Ps0015 377, Ostrowiec Świętokrzyski

Ps0015 368, Wroclaw

Ps0015 375, Wroclaw

Ps0015 455, Alicante

Ps0015 450, Barcelona

Ps0015 451, Madrid

Ps0015 454, Madrid

Ps0015 456, Madrid

Ps0015 457, Sant Joan Despí

Ps0015 763, Gaziantep

Ps0015 762, Istanbul

Ps0015 760, Kayseri

Ps0015 559, Newcastle upon Tyne

Ps0015 555, Salford